| SUBJECT： |
Discovery Chemistry Congress |
| DATE： |
2013-03-19 |
| LOCATION： |
Munich, Germany |
| CONTENT： |
Official Information:
Previous problems with drug discovery led to considerable investment, by the pharmaceutical industry, in combinatorial and discovery chemistry. This conference will integrate the latest structural chemistry with innovative discovery-driven technologies. Taking place in Munich for the second year running, speakers will concentrate on the most important aspects of discovery stages for effective drug design and refinement.
In the current economic climate there is increasing global competitiveness and financial pressure, therefore, this conference aims to explore the options available to maximise the success of drug discovery and development. Our speakers have collaborated to provide four accessible tracks:
• Fragment-based Lead Discovery
• Targeting Protein-protein Interactions
• Formulation & Solubility
• Chemical Biology
The tracks offered work synergistically to overcome the challenges of drug delivery in a completely new way. Select Biosciences hope to help delegates convert this expensive, challenging and inefficient process into a more accessible and affordable one.
Keynote Speakers:
Roderic Hubbard, Professor, University of York
Helena Danielson, Professor, Uppsala University
Mark Bradley, Professor/Principal Investigator, University of Edinburgh
Jennifer Laurence, Associate Professor, University of Kansas
Sven Stegemann, Director, Pfizer
|
| Original file： |
No File
|
|
| Promulgator Detail |
| Contact: |
admin |
| Tel: |
|
| Fax: |
|
| E-mail: |
reply |
| Address: |
Munich, Germany |
| Website: |
|
|
|
